Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM)

Diabetic Medicine

Volumn 13, Issue SUPPL. 6, 1996, Pages

  Westermark, P ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Amylin; Amyloid; Fibrosis; Islet amyloid polypeptide

Indexed keywords

AMYLIN;

ANIMAL TISSUE; CAT; CONFERENCE PAPER; FIBROSIS; HAMSTER; HUMAN; HUMAN TISSUE; MONKEY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; RAT;

EID: 0029834795     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/dme.1996.13.s6.46     Document Type: Conference Paper

References (23)

1. Westermark P, Wilander E. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 1978; 15: 417-421.
2. Clark A, Saad MF, Nezzer T, et al. Islet amyloid polypeptide in diabetic and non-diabetic Pima indians. Diabetologia 1990; 33: 285-289.
3. Narita RHT, Toshimori H, Nakazato M, et al. Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients. Diab Res Clin Pract 1992; 15: 3-14.
4. Westermark P, Wernstedt C, Wilander E, et al. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 1986; 140: 827-831.
5. Lorenzo A, Razzaboni B, Weir GC, et al. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 1994; 368: 756-760.
6. Westermark P, Grimelius L. The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Path Microbiol Scand A 1973; 81: 291-300.
7. Klöppel G, Löhr M, Habich K, et al. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Path Res 1985; 4: 110-125.
8. Clark A, Wells CA, Buley ID, et al. Islet amyloid, increased A-cells, reduced β-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diab Res 1988; 9: 151-159.
9. Maloy AL, Longnecker DS, Greeberg ER. The relation of islet amyloid to the clinical type of diabetes. Hum Path 1981; 12: 917-922.
10. Westermark P. Amyloid and polypeptide hormones: what is their inter-relationship? Amyloid 1994; 1: 47-60.
11. Betsholtz C, Christmanson L, Engström U, et al. Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett 1989; 251: 261-264.
12. Nishi M, Chan SJ, Nagamatsu S, et al. Conservation of the sequence of islet amyloid polypeptide in five mammals is consistent with its putative role as an islet hormone. Proc Natl Acad Sci USA 1989; 86: 5738-5742.
13. Betsholtz C, Christmanson L, Engström U, et al. Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes 1990; 39: 118-122.
14. Ohagi S, Nishi M, Bell GI, et al. Sequences of islet amyloid polypeptide precursors of an old world monkey, the pig-tailed macaque (Macaca nemestrina), and the dog (Canis familiaris). Diabetologia 1991; 34: 555-558.
15. Westermark P, Engström U, Johnson KH, et al. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 1990; 87: 5036-5040.
16. Nishi M, Bell GI, Steiner DF. Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor sequence in 25 type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1990; 33: 628-630.
17. Sanke T, Hanabusa T, Nakano Y, et al. Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 129-132.
18. Fox N, Schrementi J, Nishi M, et al. Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM). FEBS Lett 1993; 323: 40-44.
19. Höppener JWM, Verbeek JS, de Koning EJP, et al. Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia. Diabetologia 1993; 36: 1258-1265.
20. Verchere CB, D'Alessio DA, Palmiter RD, et al. Transgenic mice overproducing islet amyloid polypeptide have increased insulin storage and secretion in vitro. Diabetologia 1994; 37: 725-728.
21. Westermark G, Benig Arona M, Fox N, et al. Amyloid formation in vitro but not in vivo in response to β-cell stress in islets of transgenic mice expressing human islet amyloid polypeptide. Mol Med 1995; 1: 542-553.
22. de Koning EPJ, Morris ER, Hofhuis FMA, et al. Intraand extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA 1994; 91: 8467-8471.
23. Westermark P, Eizirik DE, Pipeleers DG, et al. Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia, 1995; 38: 543-549.